×




Strategic Deal Making at Millennium Pharmaceuticals Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Strategic Deal Making at Millennium Pharmaceuticals case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Strategic Deal Making at Millennium Pharmaceuticals case study is a Harvard Business School (HBR) case study written by Michael D. Watkins, Sarah G. Matthews. The Strategic Deal Making at Millennium Pharmaceuticals (referred as “Millennium Pharmaceuticals” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, Negotiations.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Strategic Deal Making at Millennium Pharmaceuticals Case Study


A small start-up in 1993, Millennium Pharmaceuticals was a name-brand biotechnology company by the end of 1998, with a market capitalization of $1.4 billion. The Cambridge-based company's growth strategy had relied heavily on building alliances for early-stage drug discovery and licensing its gene-based technology.


Case Authors : Michael D. Watkins, Sarah G. Matthews

Topic : Strategy & Execution

Related Areas : Negotiations




Calculating Net Present Value (NPV) at 6% for Strategic Deal Making at Millennium Pharmaceuticals Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10027165) -10027165 - -
Year 1 3458896 -6568269 3458896 0.9434 3263109
Year 2 3953867 -2614402 7412763 0.89 3518928
Year 3 3948639 1334237 11361402 0.8396 3315353
Year 4 3241965 4576202 14603367 0.7921 2567940
TOTAL 14603367 12665330




The Net Present Value at 6% discount rate is 2638165

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Profitability Index
3. Internal Rate of Return
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Millennium Pharmaceuticals have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Millennium Pharmaceuticals shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Strategic Deal Making at Millennium Pharmaceuticals

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Millennium Pharmaceuticals often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Millennium Pharmaceuticals needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10027165) -10027165 - -
Year 1 3458896 -6568269 3458896 0.8696 3007736
Year 2 3953867 -2614402 7412763 0.7561 2989691
Year 3 3948639 1334237 11361402 0.6575 2596294
Year 4 3241965 4576202 14603367 0.5718 1853604
TOTAL 10447325


The Net NPV after 4 years is 420160

(10447325 - 10027165 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10027165) -10027165 - -
Year 1 3458896 -6568269 3458896 0.8333 2882413
Year 2 3953867 -2614402 7412763 0.6944 2745741
Year 3 3948639 1334237 11361402 0.5787 2285092
Year 4 3241965 4576202 14603367 0.4823 1563448
TOTAL 9476694


The Net NPV after 4 years is -550471

At 20% discount rate the NPV is negative (9476694 - 10027165 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Millennium Pharmaceuticals to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Millennium Pharmaceuticals has a NPV value higher than Zero then finance managers at Millennium Pharmaceuticals can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Millennium Pharmaceuticals, then the stock price of the Millennium Pharmaceuticals should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Millennium Pharmaceuticals should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Strategic Deal Making at Millennium Pharmaceuticals

References & Further Readings

Michael D. Watkins, Sarah G. Matthews (2018), "Strategic Deal Making at Millennium Pharmaceuticals Harvard Business Review Case Study. Published by HBR Publications.


Treatt PLC SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Cherry Hill Mortgage SWOT Analysis / TOWS Matrix

Financial , Consumer Financial Services


PC Direct SWOT Analysis / TOWS Matrix

Technology , Computer Hardware


Shanghai Laiyifen SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Chitose Internasional SWOT Analysis / TOWS Matrix

Capital Goods , Constr. - Supplies & Fixtures


Le Mare Gold SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Cinemark SWOT Analysis / TOWS Matrix

Services , Motion Pictures


Kaitori Okoku SWOT Analysis / TOWS Matrix

Services , Retail (Specialty)


Destiny Pharma SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Novation Hldgs Inc. SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


TPR Co Ltd SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts